Difference between revisions of "Part:BBa K2549036"
m |
(→Our characterization) |
||
(3 intermediate revisions by the same user not shown) | |||
Line 13: | Line 13: | ||
===Biology=== | ===Biology=== | ||
=====Our characterization===== | =====Our characterization===== | ||
− | [[File:AND-test.png|none|480px|thumb|'''CfaN intein-based AND gate.''' A degradable EGFP (d2EGFP) is produced downstream the promoter of the Combiner to indicate the output strength. DBD, DNA binding domain which is zinc finger in our assay. AD, activating-form transcriptional domain, was VP64. RE, responsive elements. RFI, relative fluorescence intensity (comparing before and after activation). | + | [[File:AND-test.png|none|480px|thumb|'''CfaN intein-based AND gate.''' A degradable EGFP (d2EGFP) is produced downstream the promoter of the Combiner to indicate the output strength. DBD, DNA binding domain which is zinc finger in our assay. AD, activating-form transcriptional domain, was VP64. RE, responsive elements. RFI, relative fluorescence intensity (comparing before and after activation). More details please visit http://2018.igem.org/Team:Fudan/Results and http://2018.igem.org/Team:Fudan/Measurement .]] |
− | + | ||
− | + | ||
+ | We show that when VP64-ZF21.16N-CfaN co-expressed with CfaC-ZF21.16C-NLS, the expression level of d2EGFP is relatively turned up due to the formation of VP64-ZF21.16 after auto-plicing and ligation. The signal-noise-ratio is still not optimal, and we are improving the design by switching the split position as well as adding linkers. Please note [[Part:BBa_K2549036]] contains a transcriptional activation domain VP64, while [[Part:BBa_K2549037]] has a transcriptional repression domain KRAB. | ||
=====Boolean logic gates via split zinc finger-based transcription factors===== | =====Boolean logic gates via split zinc finger-based transcription factors===== |
Latest revision as of 21:37, 17 October 2018
VP64-ZF21.16N-CfaN
This part is one of the downstream elements of our amplifier. It is constructed by fusing VP64 (Part:BBa_K2549057), G4S linker (Part:BBa_K2549053), ZF21.16N (Part:BBa_K2549011) and CfaN (Part:BBa_K2549009), from N terminal to C terminal. VP64 is a tetrameric VP16 transcription activator which shows ultrahigh transcription activation function. G4S is a glycine-rich peptide linker whose sequence is GGGGS. ZF21.16N is the N-terminal fragment of the zinc finger whose recognition helices for three-finger arrays are substituted by the reported synthetic zinc finger 21.16 residues on the basis of the BCR_ABL-1 artificial zinc finger[1]. CfaN is the N-terminal fragment of Cfa which is a consensus sequence from an alignment of 73 naturally occurring DnaE inteins that are predicted to have fast splicing rates. When coexpressed with CfaC-ZF21.16C-NLS (Part:BBa_K2549038) in the same cell, both fusions will be produced and a transcription activating function will be executed.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Biology
Our characterization
We show that when VP64-ZF21.16N-CfaN co-expressed with CfaC-ZF21.16C-NLS, the expression level of d2EGFP is relatively turned up due to the formation of VP64-ZF21.16 after auto-plicing and ligation. The signal-noise-ratio is still not optimal, and we are improving the design by switching the split position as well as adding linkers. Please note Part:BBa_K2549036 contains a transcriptional activation domain VP64, while Part:BBa_K2549037 has a transcriptional repression domain KRAB.
Boolean logic gates via split zinc finger-based transcription factors
Lohmueller JJ et al have demonstrated the split ZF-TF reconstitution process. Please note that we used Cfa split intein (Part:BBa_K2549009 and Part:BBa_K2549010) but not dnaB reported below.
References
- ↑ A tunable zinc finger-based framework for Boolean logic computation in mammalian cells. Lohmueller JJ, Armel TZ, Silver PA. Nucleic Acids Res, 2012 Jun;40(11):5180-7 PMID: 22323524; DOI: 10.1093/nar/gks142